Nykredit

LEO Pharma delivers solid first half-year results and strengthens its capital structure

Retrieved on: 
Tuesday, September 12, 2023

As a result of the solid first half year results, LEO Pharma is now upwards revising its outlook for 2023.

Key Points: 
  • As a result of the solid first half year results, LEO Pharma is now upwards revising its outlook for 2023.
  • Today, LEO Pharma also announced a new capital structure that enables the company to pursue value accretive Business Development and M&A opportunities supporting continued long-term growth.
  • The LEO Foundation has taken the opportunity to simplify and further strengthen the capital structure by converting its existing shareholder loans into equity in LEO Pharma.
  • Together with our owners and relationship banks, we have now secured a capital structure that supports the future growth both organically and through acquisitions.”
    Peter Haahr, CEO of the LEO Foundation said:
    “The solid half-year results and strengthened capital structure represent an important milestone in LEO Pharma’s transformation.

Nykredit Asset Management Adopts Bloomberg Buy-Side Solutions to Streamline Front Office Workflow and Data Management

Retrieved on: 
Tuesday, September 12, 2023

Nykredit Asset Management will utilize Bloomberg AIM, a leading order and investment management technology solution, to streamline its multi-asset order management operations while integrating trading connectivity for multiple asset classes.

Key Points: 
  • Nykredit Asset Management will utilize Bloomberg AIM, a leading order and investment management technology solution, to streamline its multi-asset order management operations while integrating trading connectivity for multiple asset classes.
  • Data management will be optimized by using a single data set that will nourish their front office applications.
  • By implementing Bloomberg's integrated portfolio and order management systems, Nykredit Asset Management is provided a holistic view of front-office operations to better manage its portfolios across the investment lifecycle.
  • Bloomberg AIM is a leading order and investment management technology solution with multi-asset decision support and portfolio management, order management, trade compliance and post-trade workflows.

Nykredit Mægler has chosen Agillic to personalise its communication and run more effective campaigns

Retrieved on: 
Tuesday, March 14, 2023

Through Agillic's Omnichannel Marketing Automation Platform, Nykredit Mægler will be able to better personalise its communication and target specific customer segments, allowing for more effective campaigns and higher conversion rates.

Key Points: 
  • Through Agillic's Omnichannel Marketing Automation Platform, Nykredit Mægler will be able to better personalise its communication and target specific customer segments, allowing for more effective campaigns and higher conversion rates.
  • Automating marketing communication processes is set to result in increased efficiency and a higher level of customer service.
  • By providing personalised and relevant information, Nykredit Mægler seeks to help its customers find their dream homes faster, with the goal of increasing customer satisfaction and loyalty.
  • "The ability to target specific customer segments and personalise our communication is of great importance to us.

ALK appoints Claus Steensen Sølje as new Chief Financial Officer (CFO)

Retrieved on: 
Friday, February 10, 2023

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that Claus Steensen Sølje will take up the position as Executive Vice President, Chief Financial Officer (CFO) and member of the Board of Management no later than 1 June 2023.

Key Points: 
  • ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that Claus Steensen Sølje will take up the position as Executive Vice President, Chief Financial Officer (CFO) and member of the Board of Management no later than 1 June 2023.
  • Claus Steensen Sølje, born 1972, a Danish citizen, will bring extensive experience to ALK from more than 20 years in various leadership roles at Novo Nordisk in Denmark, France and Switzerland.
  • Previously, Claus Steensen Sølje has among others also been regional CFO for Novo Nordisk Emerging Markets and country CFO for Novo Nordisk France.
  • Claus Steensen Sølje holds an M.Sc.